The Minnesota Timberwolves are reported to be at the forefront of the NBA’s efforts to combat COVID-19. As reported by ESPN‘s Malika Andrews, the Wolves are partnering with the Minnesota-based Mayo Clinic to conduct an antibody study that will include all 30 teams in the league.
All 30 NBA teams are expected to participate in a coronavirus antibody study, spearheaded by Timberwolves’ Dr. Robby Sikka. Researchers hope the results offer a better understanding of the spread of the disease in the league and society. ESPN story: https://t.co/p8LUmdVELc
— Malika Andrews (@malika_andrews) May 20, 2020
The NBA’s participation in an antibody study was announced earlier this month, with the partnership with the Mayo Clinic now laying-out the structure for the study.
The COVID-19 pandemic hits especially close to home for the Timberwolves, as both of center Karl-Anthony Towns’ parents were afflicted by the novel coronavirus, and Towns’ mother tragically losing her life to the disease.
The NBA is currently in the process of a gradual re-opening of its practice facilities, with the league into its second month of a suspended season due to the ongoing pandemic.
Additional Resources: Read BetterHelp’s article on online therapy and why it’s important especially dying this pandemic.
